Literature DB >> 11024361

The use of recombinant antibodies in proteomics.

L J Holt1, C Enever, R M de Wildt, I M Tomlinson.   

Abstract

Recombinant antibodies are becoming increasingly important in the field of proteomics. Recent advances include the development of large phage-antibody libraries that contain high-affinity binders to almost any target protein, and new methods for high-throughput selection of antibody-antigen interactions. Coupled with a range of new screening technologies that use high-density antibody arrays to identify differentially expressed proteins, these antibody libraries can be applied to whole proteome analysis.

Mesh：

Substances：

Year:  2000        PMID： 11024361     DOI： 10.1016/s0958-1669(00)00133-6

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  15 in total

1.  Selective immobilization of proteins to self-assembled monolayers presenting active site-directed capture ligands.

Authors:  Christian D Hodneland; Young-Sam Lee; Dal-Hee Min; Milan Mrksich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 2.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

3.  Selecting open reading frames from DNA.

Authors:  Paola Zacchi; Daniele Sblattero; Fiorella Florian; Roberto Marzari; Andrew R M Bradbury
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

Review 4.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

Review 5.  Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Authors:  Kelli B Pointer; Paul A Clark; Michael Zorniak; Bahauddeen M Alrfaei; John S Kuo
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

6.  pMINERVA: A donor-acceptor system for the in vivo recombineering of scFv into IgG molecules.

Authors:  M Batonick; M M Kiss; E P Fuller; C M Magadan; E G Holland; Q Zhao; D Wang; B K Kay; M P Weiner
Journal:  J Immunol Methods       Date:  2016-02-03       Impact factor: 2.303

7.  Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.

Authors:  Tayebeh Mehdipour; Mohammad R Tohidkia; Amir Ata Saei; Amir Kazemi; Shirin Khajeh; Ali A Rahim Rahimi; Sepideh Nikfarjam; Mehrdad Farhadi; Monireh Halimi; Ramin Soleimani; Roman A Zubarev; Mohammad Nouri
Journal:  Immunology       Date:  2019-11-08       Impact factor: 7.397

8.  Multiplexed protein profiling on microarrays by rolling-circle amplification.

Authors:  Barry Schweitzer; Scott Roberts; Brian Grimwade; Weiping Shao; Minjuan Wang; Qin Fu; Quiping Shu; Isabelle Laroche; Zhimin Zhou; Velizar T Tchernev; Jason Christiansen; Mark Velleca; Stephen F Kingsmore
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

9.  The use of phage display to generate conformation-sensor recombinant antibodies.

Authors:  Aftabul Haque; Nicholas K Tonks
Journal:  Nat Protoc       Date:  2012-11-15       Impact factor: 13.491

10.  Fluorescence-activated cell sorting of specific affibody-displaying staphylococci.

Authors:  Henrik Wernérus; Patrik Samuelson; Stefan Ståhl
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.